SC 13G Filing

Company

Akari Therapeutics Plc

Filed

September 21, 2015

Accession Number

0001193805-15-001614

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →